Haryana govt ready to implement Clinical Establishment Act with IMA’s slew of demands

  • News
  • January 6, 2018

With an aim to clear decks for implementation of Central Clinical Establishment Act to regulate healthcare facilities in the state, the Haryana government has agreed to Indian Medical Association (IMA)’s slew of demands including exemption of 50 bedded hospitals from the purview of the  Clinical Establishment Act, dropping penal provision on doctors, and setting up of district redressal mechanism having doctors’ representation.

The Haryana government has modified Central Clinical Establishment Act to address IMA concerns and would soon issue an ordinance to implement it. The hospitals with more than 50 beds would be covered under it.

The government agreed to demands of IMA at a meeting held a couple of days back. Dr KK Aggarwal, National President of IMA said “We have long been demanding for exemption of hospitals having less than 50 beds from central act and dropping penal provision on physicians. We are happy that government has agreed to them.”

Besides this, the government has also agreed to other demands of IMA such as allowing it to accreditate all clinics and establishments up to 50 beds and certify all paramedics working in various establishments. IMA Paramedical council will certify all paramedics in several establishments.

The government has also given its consent for imposition of IMA self-regulations on all establishments. 50 beds which will have only registration will also comply with IMA self- regulations. Those not following IMA regulations will be boycotted by the association, opined Dr Aggarwal.

It also agreed to set up district redressal mechanism which will provide single window accountability and will have IMA members in it and medical negligence will be looked by Haryana Medical Council.

IMA had expressed reservations over certain provisions in the central act including fixing fee structures of doctors’ prescription and treatment, and provision to treat trauma patients free of cost as it will affect small-scale private hospitals, making it difficult for them to operate.

Allaying apprehensions of IMA, the government has made it clear that standard treatment guidelines mentioned in CEA will be advisory in nature and will be framed in consultation with the largest body of doctors.

It further said that charges will be transparent and displayed and will be in consultation with IMA.

Earlier an association of doctors on December 15, 2017 suspended all outpatient services (OPD) at around 185 private hospitals in protest against the Haryana government’s decision to implement the central act.

  • Related Posts

    13 Years after Oxytocin Order, HC Seeks Compilance Status

    GWALIOR: The Gwalior Bench of the Madhya Pradesh High Court has directed the state government to submit a comprehensive compliance status report. This order addresses the implementation of the court’s…

    Centre Pushes Haryana to Fast-Track AIIMS Rewari

    New Delhi | August 18, 2025 — The Union government has urged Haryana to speed up work on AIIMS Rewari (Majra) and resolve on-ground hurdles so the institute can open…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Annovis Bio receives US patent covering new crystalline form of buntanetap

    Annovis Bio receives US patent covering new crystalline form of buntanetap

    Bengaluru: Medical devices worth ₹13.79 lakh seized in enforcement drive

    Bengaluru: Medical devices worth ₹13.79 lakh seized in enforcement drive

    Yashoda Medicity Unveils T-Shirts & Finisher Medals ahead of Yashoda Half Marathon 4.0

    Yashoda Medicity Unveils T-Shirts & Finisher Medals ahead of Yashoda Half Marathon 4.0

    PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

    PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

    Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

    Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

    From ‘Kidney Care’ to ‘Liver Detox’, Uttar Pradesh bans misleading supplement labels

    From ‘Kidney Care’ to ‘Liver Detox’, Uttar Pradesh bans misleading supplement labels